Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Helicobacter Infections | 29 | 2020 | 1263 | 2.070 |
Why?
|
Helicobacter pylori | 30 | 2020 | 1319 | 1.920 |
Why?
|
Breath Tests | 23 | 2018 | 178 | 1.780 |
Why?
|
Carbohydrate Metabolism, Inborn Errors | 8 | 2018 | 36 | 1.550 |
Why?
|
Esomeprazole | 3 | 2018 | 31 | 1.170 |
Why?
|
Caliciviridae Infections | 14 | 2023 | 328 | 1.080 |
Why?
|
Sucrase-Isomaltase Complex | 6 | 2018 | 19 | 0.980 |
Why?
|
Norwalk virus | 13 | 2015 | 170 | 0.970 |
Why?
|
Starch | 5 | 2018 | 25 | 0.870 |
Why?
|
Gastrointestinal Agents | 3 | 2018 | 60 | 0.860 |
Why?
|
Malabsorption Syndromes | 3 | 2020 | 36 | 0.830 |
Why?
|
Gastroenteritis | 11 | 2023 | 349 | 0.830 |
Why?
|
Disaccharidases | 2 | 2020 | 14 | 0.830 |
Why?
|
Immunoenzyme Techniques | 2 | 2020 | 258 | 0.720 |
Why?
|
Urea | 12 | 2009 | 226 | 0.700 |
Why?
|
Digestion | 4 | 2018 | 41 | 0.680 |
Why?
|
Feces | 6 | 2023 | 725 | 0.650 |
Why?
|
Amoxicillin | 4 | 2010 | 121 | 0.640 |
Why?
|
Sucrose | 3 | 2016 | 39 | 0.630 |
Why?
|
Enzyme Therapy | 1 | 2018 | 5 | 0.620 |
Why?
|
Point-of-Care Systems | 3 | 2006 | 172 | 0.600 |
Why?
|
Antigens, Bacterial | 3 | 2020 | 314 | 0.600 |
Why?
|
Lactobacillus delbrueckii | 1 | 2018 | 2 | 0.600 |
Why?
|
Crohn Disease | 5 | 2024 | 283 | 0.590 |
Why?
|
Norovirus | 5 | 2023 | 317 | 0.550 |
Why?
|
Gastrointestinal Diseases | 1 | 2020 | 336 | 0.510 |
Why?
|
Dietary Carbohydrates | 3 | 2012 | 119 | 0.500 |
Why?
|
Anti-Bacterial Agents | 7 | 2018 | 2426 | 0.500 |
Why?
|
Irritable Bowel Syndrome | 1 | 2018 | 206 | 0.500 |
Why?
|
Immunoglobulin G | 10 | 2015 | 777 | 0.490 |
Why?
|
Abdominal Pain | 2 | 2012 | 310 | 0.480 |
Why?
|
Glucose | 4 | 2020 | 880 | 0.470 |
Why?
|
Cells | 1 | 2014 | 27 | 0.450 |
Why?
|
Gastric Mucosa | 6 | 2006 | 486 | 0.450 |
Why?
|
Antibodies, Viral | 10 | 2015 | 1151 | 0.450 |
Why?
|
Cytoplasm | 1 | 2014 | 290 | 0.420 |
Why?
|
Carbon Isotopes | 9 | 2018 | 277 | 0.410 |
Why?
|
Intestinal Mucosa | 6 | 2019 | 776 | 0.410 |
Why?
|
Adult | 56 | 2021 | 29438 | 0.400 |
Why?
|
Intestine, Small | 4 | 2024 | 309 | 0.400 |
Why?
|
Colon | 3 | 2024 | 349 | 0.380 |
Why?
|
Cell Nucleus | 1 | 2014 | 676 | 0.370 |
Why?
|
Anti-Ulcer Agents | 7 | 2005 | 110 | 0.360 |
Why?
|
Humans | 100 | 2024 | 124596 | 0.360 |
Why?
|
Male | 71 | 2024 | 61192 | 0.350 |
Why?
|
Middle Aged | 47 | 2020 | 26714 | 0.340 |
Why?
|
Fasting | 2 | 2020 | 298 | 0.310 |
Why?
|
Female | 64 | 2021 | 66485 | 0.300 |
Why?
|
Antibodies, Bacterial | 5 | 2006 | 388 | 0.300 |
Why?
|
Spectrophotometry, Infrared | 2 | 2005 | 20 | 0.300 |
Why?
|
Duodenum | 3 | 2018 | 99 | 0.290 |
Why?
|
Virus Cultivation | 2 | 2019 | 76 | 0.290 |
Why?
|
Prospective Studies | 13 | 2020 | 6135 | 0.290 |
Why?
|
Anti-Infective Agents | 2 | 2006 | 264 | 0.260 |
Why?
|
Colitis, Ulcerative | 3 | 2015 | 205 | 0.260 |
Why?
|
Urease | 4 | 2020 | 73 | 0.250 |
Why?
|
Fluoroquinolones | 1 | 2006 | 93 | 0.250 |
Why?
|
Yogurt | 1 | 2005 | 13 | 0.250 |
Why?
|
Brassica | 1 | 2005 | 14 | 0.240 |
Why?
|
Sensitivity and Specificity | 5 | 2020 | 2050 | 0.240 |
Why?
|
Virus Replication | 4 | 2019 | 610 | 0.240 |
Why?
|
Viral Vaccines | 4 | 2015 | 333 | 0.230 |
Why?
|
Bacteriological Techniques | 1 | 2005 | 87 | 0.230 |
Why?
|
Gastric Acidity Determination | 3 | 2004 | 19 | 0.220 |
Why?
|
Biomarkers | 6 | 2020 | 3063 | 0.210 |
Why?
|
Hydrogen-Ion Concentration | 8 | 2010 | 432 | 0.210 |
Why?
|
Aged | 19 | 2020 | 19703 | 0.200 |
Why?
|
Reproducibility of Results | 3 | 2020 | 2876 | 0.200 |
Why?
|
Biopsy | 6 | 2020 | 1237 | 0.200 |
Why?
|
Probiotics | 1 | 2005 | 214 | 0.200 |
Why?
|
Immunoglobulin A | 7 | 2015 | 208 | 0.190 |
Why?
|
Drug Therapy, Combination | 8 | 2010 | 1162 | 0.190 |
Why?
|
Proton Pump Inhibitors | 4 | 2010 | 259 | 0.190 |
Why?
|
Gastric Emptying | 2 | 2021 | 78 | 0.190 |
Why?
|
Virus Shedding | 5 | 2023 | 80 | 0.180 |
Why?
|
Celiac Disease | 2 | 2003 | 67 | 0.180 |
Why?
|
Omeprazole | 5 | 2006 | 98 | 0.180 |
Why?
|
Liver Cirrhosis | 2 | 2018 | 831 | 0.180 |
Why?
|
Electrodes | 2 | 1991 | 98 | 0.180 |
Why?
|
Adolescent | 24 | 2021 | 19280 | 0.180 |
Why?
|
Pilot Projects | 6 | 2020 | 1387 | 0.180 |
Why?
|
Lactose | 2 | 2006 | 54 | 0.170 |
Why?
|
Gastroparesis | 1 | 2021 | 67 | 0.170 |
Why?
|
Liver | 3 | 2017 | 1739 | 0.170 |
Why?
|
Fermentation | 1 | 2020 | 66 | 0.170 |
Why?
|
Sucrase | 2 | 2017 | 23 | 0.160 |
Why?
|
Circadian Clocks | 1 | 2020 | 59 | 0.160 |
Why?
|
Sialic Acids | 1 | 1999 | 20 | 0.160 |
Why?
|
Proteome | 1 | 2020 | 243 | 0.150 |
Why?
|
Dyspepsia | 2 | 2018 | 100 | 0.150 |
Why?
|
Postprandial Period | 1 | 2018 | 77 | 0.150 |
Why?
|
Lactoferrin | 1 | 1999 | 78 | 0.150 |
Why?
|
Millets | 1 | 2018 | 2 | 0.150 |
Why?
|
Sorghum | 1 | 2018 | 3 | 0.150 |
Why?
|
Young Adult | 9 | 2020 | 9014 | 0.150 |
Why?
|
Satiety Response | 1 | 2018 | 32 | 0.150 |
Why?
|
Glomerular Filtration Rate | 2 | 2018 | 503 | 0.150 |
Why?
|
Rural Health | 1 | 2018 | 50 | 0.150 |
Why?
|
Pancreatin | 1 | 1997 | 5 | 0.150 |
Why?
|
Glucan 1,4-alpha-Glucosidase | 1 | 2017 | 6 | 0.140 |
Why?
|
Seeds | 1 | 2018 | 42 | 0.140 |
Why?
|
Tumor Suppressor Proteins | 1 | 2020 | 465 | 0.140 |
Why?
|
Cystatin C | 1 | 2018 | 59 | 0.140 |
Why?
|
Saliva | 2 | 2015 | 114 | 0.140 |
Why?
|
Pancreas | 1 | 2018 | 218 | 0.140 |
Why?
|
Genetic Variation | 1 | 2024 | 1497 | 0.140 |
Why?
|
Exocrine Pancreatic Insufficiency | 1 | 1997 | 34 | 0.140 |
Why?
|
Stem Cells | 2 | 2019 | 692 | 0.140 |
Why?
|
Metabolic Syndrome | 1 | 2020 | 338 | 0.140 |
Why?
|
Famotidine | 2 | 2004 | 9 | 0.140 |
Why?
|
Adjuvants, Immunologic | 1 | 1999 | 381 | 0.130 |
Why?
|
DNA Methylation | 2 | 2014 | 1003 | 0.130 |
Why?
|
Liver Function Tests | 2 | 1995 | 100 | 0.130 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 6 | 2015 | 822 | 0.130 |
Why?
|
Radiopharmaceuticals | 1 | 2016 | 162 | 0.120 |
Why?
|
Contraceptives, Oral | 1 | 1995 | 37 | 0.120 |
Why?
|
Dietary Supplements | 2 | 2017 | 476 | 0.120 |
Why?
|
Renal Insufficiency | 1 | 2018 | 236 | 0.120 |
Why?
|
Organ Culture Techniques | 1 | 2015 | 155 | 0.120 |
Why?
|
Blood Cells | 1 | 2015 | 49 | 0.120 |
Why?
|
Gastric Acid | 1 | 1995 | 50 | 0.120 |
Why?
|
Vaccines, Virus-Like Particle | 1 | 2015 | 33 | 0.120 |
Why?
|
Epithelial Cells | 1 | 2019 | 909 | 0.120 |
Why?
|
Antimony | 2 | 1991 | 14 | 0.120 |
Why?
|
Clarithromycin | 4 | 2009 | 125 | 0.120 |
Why?
|
Leukocytes, Mononuclear | 2 | 2015 | 325 | 0.110 |
Why?
|
Subcellular Fractions | 1 | 2014 | 97 | 0.110 |
Why?
|
Cross Reactions | 1 | 2014 | 192 | 0.110 |
Why?
|
Metabolomics | 1 | 2017 | 422 | 0.110 |
Why?
|
Case-Control Studies | 4 | 2018 | 3281 | 0.110 |
Why?
|
Cytosol | 1 | 2014 | 161 | 0.110 |
Why?
|
Child | 14 | 2023 | 24375 | 0.110 |
Why?
|
Organoids | 1 | 2016 | 282 | 0.110 |
Why?
|
Tissue and Organ Harvesting | 1 | 2013 | 40 | 0.110 |
Why?
|
Immunomodulation | 1 | 2013 | 81 | 0.110 |
Why?
|
Models, Theoretical | 1 | 2015 | 358 | 0.110 |
Why?
|
Antibody Formation | 2 | 2012 | 266 | 0.100 |
Why?
|
Brain Death | 1 | 2013 | 59 | 0.100 |
Why?
|
Gastritis | 5 | 2004 | 371 | 0.100 |
Why?
|
Protein Transport | 1 | 2014 | 369 | 0.100 |
Why?
|
Organometallic Compounds | 5 | 2005 | 107 | 0.100 |
Why?
|
Gastrointestinal Microbiome | 1 | 2020 | 700 | 0.100 |
Why?
|
Rotavirus Infections | 1 | 2015 | 355 | 0.100 |
Why?
|
Hemagglutination, Viral | 1 | 2011 | 10 | 0.100 |
Why?
|
Rotavirus | 1 | 2015 | 498 | 0.100 |
Why?
|
Campylobacter Infections | 5 | 1990 | 34 | 0.100 |
Why?
|
Treatment Outcome | 8 | 2017 | 12322 | 0.090 |
Why?
|
Antigens, Viral | 2 | 2012 | 439 | 0.090 |
Why?
|
Siblings | 1 | 2012 | 197 | 0.090 |
Why?
|
Peptide Hydrolases | 1 | 2012 | 141 | 0.090 |
Why?
|
Cross-Over Studies | 3 | 2018 | 313 | 0.090 |
Why?
|
Enteral Nutrition | 1 | 2013 | 256 | 0.090 |
Why?
|
Fluoroimmunoassay | 1 | 2011 | 6 | 0.090 |
Why?
|
Administration, Oral | 7 | 2017 | 680 | 0.090 |
Why?
|
Inflammation | 2 | 2020 | 1431 | 0.090 |
Why?
|
Drug Resistance, Bacterial | 3 | 2009 | 364 | 0.090 |
Why?
|
Antibodies, Neutralizing | 1 | 2014 | 468 | 0.090 |
Why?
|
Lipoproteins | 2 | 2002 | 179 | 0.090 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2014 | 616 | 0.090 |
Why?
|
Diet | 1 | 2018 | 1136 | 0.090 |
Why?
|
Kidney | 1 | 2017 | 1358 | 0.090 |
Why?
|
Silver Compounds | 1 | 1990 | 6 | 0.090 |
Why?
|
Time Factors | 9 | 2023 | 6292 | 0.090 |
Why?
|
Antibodies, Blocking | 1 | 2010 | 61 | 0.090 |
Why?
|
Critical Illness | 1 | 1995 | 603 | 0.090 |
Why?
|
Sirolimus | 2 | 2002 | 222 | 0.090 |
Why?
|
Models, Biological | 2 | 2014 | 1459 | 0.090 |
Why?
|
Endoscopy, Gastrointestinal | 3 | 2007 | 241 | 0.090 |
Why?
|
Cytochrome P-450 CYP2C19 | 1 | 2010 | 19 | 0.090 |
Why?
|
Serologic Tests | 2 | 2011 | 118 | 0.080 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 1 | 2010 | 43 | 0.080 |
Why?
|
Cell Line | 2 | 2014 | 2749 | 0.080 |
Why?
|
Child, Preschool | 11 | 2018 | 14009 | 0.080 |
Why?
|
Endoscopy, Digestive System | 2 | 2018 | 149 | 0.080 |
Why?
|
Histamine H2 Antagonists | 2 | 2004 | 49 | 0.080 |
Why?
|
beta-Fructofuranosidase | 1 | 2009 | 2 | 0.080 |
Why?
|
Condiments | 1 | 1988 | 3 | 0.080 |
Why?
|
Clinical Protocols | 2 | 2008 | 240 | 0.080 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2012 | 1016 | 0.080 |
Why?
|
Critical Care | 1 | 1994 | 657 | 0.080 |
Why?
|
Ranitidine | 2 | 2005 | 31 | 0.070 |
Why?
|
Drug Administration Schedule | 3 | 2006 | 721 | 0.070 |
Why?
|
Citric Acid | 2 | 2005 | 36 | 0.070 |
Why?
|
MicroRNAs | 1 | 2015 | 835 | 0.070 |
Why?
|
Immunosuppressive Agents | 2 | 2002 | 647 | 0.070 |
Why?
|
Apolipoproteins B | 2 | 2001 | 133 | 0.070 |
Why?
|
Kidney Transplantation | 3 | 2002 | 643 | 0.070 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2012 | 304 | 0.070 |
Why?
|
Primary Health Care | 2 | 2005 | 771 | 0.070 |
Why?
|
alpha-Glucosidases | 1 | 2007 | 28 | 0.070 |
Why?
|
Metronidazole | 4 | 2005 | 154 | 0.070 |
Why?
|
Capsule Endoscopy | 1 | 2007 | 20 | 0.070 |
Why?
|
Galactosemias | 1 | 2006 | 14 | 0.070 |
Why?
|
Jejunum | 1 | 2007 | 129 | 0.070 |
Why?
|
Cell Differentiation | 1 | 2014 | 1887 | 0.070 |
Why?
|
Enzyme Inhibitors | 2 | 2006 | 579 | 0.070 |
Why?
|
Galactose | 1 | 2006 | 54 | 0.070 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2006 | 53 | 0.060 |
Why?
|
Pepsinogen C | 1 | 2006 | 10 | 0.060 |
Why?
|
United States | 6 | 2010 | 10887 | 0.060 |
Why?
|
Pepsinogen A | 1 | 2006 | 17 | 0.060 |
Why?
|
Medically Underserved Area | 1 | 2006 | 89 | 0.060 |
Why?
|
Cholesterol | 2 | 2002 | 537 | 0.060 |
Why?
|
Malates | 1 | 2005 | 6 | 0.060 |
Why?
|
Gastrins | 3 | 2006 | 33 | 0.060 |
Why?
|
Acetazolamide | 1 | 2005 | 30 | 0.060 |
Why?
|
Freezing | 1 | 2005 | 28 | 0.060 |
Why?
|
Mucus | 1 | 2005 | 36 | 0.060 |
Why?
|
Carbonic Anhydrase Inhibitors | 1 | 2005 | 24 | 0.060 |
Why?
|
Ascorbic Acid | 1 | 2005 | 78 | 0.060 |
Why?
|
Benzimidazoles | 1 | 2006 | 132 | 0.060 |
Why?
|
Antacids | 1 | 2005 | 26 | 0.060 |
Why?
|
Infant | 9 | 2018 | 12469 | 0.060 |
Why?
|
Nontherapeutic Human Experimentation | 1 | 2004 | 7 | 0.060 |
Why?
|
Stomach Diseases | 1 | 2005 | 57 | 0.060 |
Why?
|
Ulcer | 1 | 2005 | 48 | 0.060 |
Why?
|
Anesthesia, Local | 1 | 2005 | 48 | 0.060 |
Why?
|
Bismuth | 4 | 2000 | 79 | 0.060 |
Why?
|
Culture Media | 1 | 2005 | 182 | 0.060 |
Why?
|
Temperature | 1 | 2005 | 303 | 0.060 |
Why?
|
Specimen Handling | 1 | 2005 | 142 | 0.060 |
Why?
|
Water Microbiology | 2 | 1996 | 25 | 0.060 |
Why?
|
Water Supply | 2 | 1996 | 26 | 0.060 |
Why?
|
Placebos | 2 | 2015 | 240 | 0.060 |
Why?
|
T-Lymphocyte Subsets | 1 | 2005 | 196 | 0.060 |
Why?
|
Intestinal Diseases | 1 | 2005 | 83 | 0.050 |
Why?
|
Random Allocation | 3 | 2017 | 436 | 0.050 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2005 | 307 | 0.050 |
Why?
|
Foreign-Body Migration | 1 | 2004 | 72 | 0.050 |
Why?
|
Kinetics | 2 | 2023 | 1322 | 0.050 |
Why?
|
Granuloma | 1 | 2023 | 68 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 2 | 2024 | 3153 | 0.050 |
Why?
|
Bacterial Vaccines | 3 | 2004 | 99 | 0.050 |
Why?
|
Intussusception | 1 | 2003 | 46 | 0.050 |
Why?
|
Stress, Physiological | 2 | 1995 | 255 | 0.050 |
Why?
|
Gastroscopy | 3 | 2006 | 100 | 0.050 |
Why?
|
Office Visits | 1 | 2002 | 77 | 0.050 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2002 | 136 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 2005 | 533 | 0.050 |
Why?
|
Bayes Theorem | 1 | 2023 | 284 | 0.050 |
Why?
|
Signal Transduction | 1 | 2014 | 4501 | 0.050 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2004 | 225 | 0.050 |
Why?
|
Virion | 2 | 1999 | 147 | 0.050 |
Why?
|
Radionuclide Imaging | 1 | 2021 | 149 | 0.050 |
Why?
|
Peptic Ulcer | 2 | 1995 | 148 | 0.050 |
Why?
|
Nausea | 1 | 2021 | 83 | 0.050 |
Why?
|
Salicylates | 4 | 2000 | 53 | 0.040 |
Why?
|
Sex Factors | 2 | 2018 | 1280 | 0.040 |
Why?
|
Ursodeoxycholic Acid | 1 | 2000 | 37 | 0.040 |
Why?
|
Seroepidemiologic Studies | 1 | 2000 | 122 | 0.040 |
Why?
|
Age Factors | 3 | 2000 | 2818 | 0.040 |
Why?
|
Furazolidone | 1 | 2000 | 8 | 0.040 |
Why?
|
Duodenal Ulcer | 2 | 1991 | 127 | 0.040 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2020 | 342 | 0.040 |
Why?
|
Cholangitis, Sclerosing | 1 | 2000 | 59 | 0.040 |
Why?
|
Triglycerides | 1 | 2002 | 575 | 0.040 |
Why?
|
Tetracycline | 4 | 2005 | 77 | 0.040 |
Why?
|
Double-Blind Method | 2 | 2015 | 1637 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2000 | 1689 | 0.040 |
Why?
|
Healthy Volunteers | 1 | 2020 | 134 | 0.040 |
Why?
|
Immune System | 1 | 2020 | 90 | 0.040 |
Why?
|
Adiposity | 1 | 2020 | 190 | 0.040 |
Why?
|
Mutation | 1 | 2012 | 5825 | 0.040 |
Why?
|
Tumor Virus Infections | 1 | 1999 | 135 | 0.040 |
Why?
|
Cytoskeleton | 1 | 2020 | 178 | 0.040 |
Why?
|
Colostrum | 1 | 1999 | 56 | 0.040 |
Why?
|
Food | 2 | 1990 | 125 | 0.040 |
Why?
|
Simian virus 40 | 1 | 1999 | 199 | 0.040 |
Why?
|
Immunity, Mucosal | 2 | 2014 | 87 | 0.040 |
Why?
|
Vaccines, Synthetic | 2 | 2000 | 317 | 0.040 |
Why?
|
Tandem Mass Spectrometry | 1 | 2020 | 235 | 0.040 |
Why?
|
Creatinine | 2 | 2018 | 390 | 0.040 |
Why?
|
Plant Tubers | 1 | 2018 | 1 | 0.040 |
Why?
|
Mali | 1 | 2018 | 9 | 0.040 |
Why?
|
Solanum tuberosum | 1 | 2018 | 16 | 0.040 |
Why?
|
Triticum | 1 | 2018 | 34 | 0.040 |
Why?
|
Oryza | 1 | 2018 | 24 | 0.040 |
Why?
|
Urban Health | 1 | 2018 | 76 | 0.040 |
Why?
|
Shrews | 1 | 2017 | 5 | 0.040 |
Why?
|
Cattle | 1 | 1999 | 565 | 0.040 |
Why?
|
Texas | 2 | 2010 | 3583 | 0.040 |
Why?
|
Acute Disease | 1 | 2000 | 1110 | 0.030 |
Why?
|
Regression Analysis | 3 | 2013 | 778 | 0.030 |
Why?
|
Lipase | 1 | 1997 | 93 | 0.030 |
Why?
|
Socioeconomic Factors | 1 | 2000 | 866 | 0.030 |
Why?
|
Food Preferences | 1 | 2018 | 117 | 0.030 |
Why?
|
Host-Pathogen Interactions | 1 | 2019 | 254 | 0.030 |
Why?
|
Single-Blind Method | 1 | 1997 | 235 | 0.030 |
Why?
|
Lipid Metabolism | 1 | 2020 | 356 | 0.030 |
Why?
|
Infusions, Intravenous | 2 | 1995 | 547 | 0.030 |
Why?
|
Bile | 1 | 2016 | 46 | 0.030 |
Why?
|
Retrospective Studies | 4 | 2021 | 16314 | 0.030 |
Why?
|
DNA Repair | 1 | 2020 | 585 | 0.030 |
Why?
|
Animals, Genetically Modified | 1 | 2017 | 314 | 0.030 |
Why?
|
Patient Compliance | 3 | 2006 | 471 | 0.030 |
Why?
|
Diarrhea | 2 | 1988 | 317 | 0.030 |
Why?
|
Animals | 5 | 2020 | 34072 | 0.030 |
Why?
|
Escherichia coli Infections | 2 | 1988 | 195 | 0.030 |
Why?
|
Proteomics | 1 | 2020 | 500 | 0.030 |
Why?
|
Enterocytes | 1 | 2016 | 74 | 0.030 |
Why?
|
Aminopyrine | 1 | 1995 | 7 | 0.030 |
Why?
|
Papillomavirus Infections | 1 | 1999 | 292 | 0.030 |
Why?
|
Mixed Function Oxygenases | 1 | 1995 | 30 | 0.030 |
Why?
|
Oxidative Stress | 1 | 2020 | 802 | 0.030 |
Why?
|
Cell Culture Techniques | 1 | 2016 | 280 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 1999 | 1390 | 0.030 |
Why?
|
Autophagy-Related Proteins | 1 | 2015 | 35 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2024 | 2634 | 0.030 |
Why?
|
Cognition | 1 | 2020 | 721 | 0.030 |
Why?
|
Risk Factors | 3 | 2000 | 10270 | 0.030 |
Why?
|
Paper | 1 | 1994 | 7 | 0.030 |
Why?
|
Carbon Dioxide | 3 | 2009 | 274 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2015 | 229 | 0.030 |
Why?
|
Intubation, Gastrointestinal | 1 | 1994 | 52 | 0.030 |
Why?
|
Gene-Environment Interaction | 1 | 2015 | 121 | 0.030 |
Why?
|
Stomach Ulcer | 1 | 1994 | 92 | 0.030 |
Why?
|
Microbial Sensitivity Tests | 3 | 2004 | 794 | 0.030 |
Why?
|
False Negative Reactions | 2 | 2004 | 89 | 0.030 |
Why?
|
Cholesterol, Dietary | 1 | 1993 | 46 | 0.030 |
Why?
|
Phenotype | 1 | 2023 | 4256 | 0.030 |
Why?
|
Infant Food | 1 | 1993 | 81 | 0.030 |
Why?
|
Lysine | 1 | 1994 | 194 | 0.030 |
Why?
|
Intestinal Absorption | 1 | 2013 | 190 | 0.030 |
Why?
|
Blood Glucose | 1 | 2017 | 1138 | 0.030 |
Why?
|
Evaluation Studies as Topic | 2 | 1990 | 256 | 0.030 |
Why?
|
Leucine | 1 | 1994 | 311 | 0.030 |
Why?
|
Human Experimentation | 1 | 2012 | 36 | 0.020 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2015 | 358 | 0.020 |
Why?
|
Immunoassay | 1 | 2012 | 130 | 0.020 |
Why?
|
Campylobacter | 2 | 1989 | 25 | 0.020 |
Why?
|
Fathers | 1 | 2012 | 68 | 0.020 |
Why?
|
Dietary Proteins | 1 | 1994 | 251 | 0.020 |
Why?
|
Monitoring, Physiologic | 1 | 1994 | 368 | 0.020 |
Why?
|
Nitrofurantoin | 1 | 1991 | 9 | 0.020 |
Why?
|
Hemagglutination Inhibition Tests | 1 | 2011 | 114 | 0.020 |
Why?
|
Administration, Intranasal | 1 | 2011 | 134 | 0.020 |
Why?
|
Bombesin | 1 | 1991 | 4 | 0.020 |
Why?
|
Twins, Monozygotic | 1 | 2012 | 117 | 0.020 |
Why?
|
Diseases in Twins | 1 | 2012 | 94 | 0.020 |
Why?
|
Graft Survival | 1 | 2013 | 536 | 0.020 |
Why?
|
Hospitalization | 1 | 1999 | 1777 | 0.020 |
Why?
|
Buffers | 1 | 1990 | 31 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 2015 | 573 | 0.020 |
Why?
|
Glass | 1 | 1990 | 12 | 0.020 |
Why?
|
Silver | 1 | 1990 | 21 | 0.020 |
Why?
|
Milk, Human | 1 | 1993 | 299 | 0.020 |
Why?
|
Calibration | 1 | 1990 | 89 | 0.020 |
Why?
|
Biological Assay | 1 | 2010 | 103 | 0.020 |
Why?
|
Taiwan | 1 | 2009 | 31 | 0.020 |
Why?
|
Mice | 3 | 2020 | 17630 | 0.020 |
Why?
|
Polysaccharides | 1 | 2010 | 140 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2015 | 1022 | 0.020 |
Why?
|
Gene Expression | 1 | 2014 | 1561 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2017 | 2891 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2014 | 673 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2015 | 1882 | 0.020 |
Why?
|
Membrane Potentials | 1 | 1990 | 307 | 0.020 |
Why?
|
Liver Transplantation | 1 | 2018 | 1038 | 0.020 |
Why?
|
Mexico | 2 | 2006 | 182 | 0.020 |
Why?
|
Base Sequence | 2 | 2008 | 3090 | 0.020 |
Why?
|
Capsaicin | 1 | 1988 | 18 | 0.020 |
Why?
|
Fimbriae Proteins | 1 | 1988 | 20 | 0.020 |
Why?
|
Computer Systems | 1 | 1988 | 38 | 0.020 |
Why?
|
Genotype | 1 | 2014 | 2556 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2013 | 775 | 0.020 |
Why?
|
Apolipoprotein B-100 | 2 | 2001 | 35 | 0.020 |
Why?
|
Transcriptome | 1 | 2015 | 952 | 0.020 |
Why?
|
Equipment Design | 1 | 1990 | 596 | 0.020 |
Why?
|
Imidazoles | 1 | 2009 | 194 | 0.020 |
Why?
|
Colicins | 1 | 1988 | 4 | 0.020 |
Why?
|
Isomaltose | 1 | 2007 | 1 | 0.020 |
Why?
|
Acarbose | 1 | 2007 | 4 | 0.020 |
Why?
|
Chromosomes, Bacterial | 1 | 1988 | 64 | 0.020 |
Why?
|
Maltose | 1 | 2007 | 16 | 0.020 |
Why?
|
DNA Primers | 1 | 2008 | 657 | 0.020 |
Why?
|
Endoscopy | 1 | 2009 | 280 | 0.020 |
Why?
|
Esophagus | 1 | 1989 | 216 | 0.020 |
Why?
|
Aspirin | 1 | 1988 | 223 | 0.020 |
Why?
|
Galactitol | 1 | 2006 | 2 | 0.020 |
Why?
|
Galactosephosphates | 1 | 2006 | 4 | 0.020 |
Why?
|
Escherichia coli Proteins | 1 | 1988 | 305 | 0.020 |
Why?
|
Pepsinogens | 1 | 2006 | 7 | 0.020 |
Why?
|
Rabeprazole | 1 | 2006 | 5 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2007 | 256 | 0.020 |
Why?
|
RNA, Viral | 1 | 2008 | 540 | 0.020 |
Why?
|
2-Pyridinylmethylsulfinylbenzimidazoles | 1 | 2006 | 27 | 0.020 |
Why?
|
DNA, Bacterial | 1 | 1988 | 478 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2015 | 2521 | 0.020 |
Why?
|
False Positive Reactions | 1 | 2006 | 144 | 0.020 |
Why?
|
Pain | 1 | 1989 | 454 | 0.020 |
Why?
|
Gastroesophageal Reflux | 1 | 1989 | 295 | 0.020 |
Why?
|
Chromosomes, Human, X | 1 | 2006 | 157 | 0.020 |
Why?
|
Escherichia coli | 2 | 1988 | 985 | 0.020 |
Why?
|
Family Health | 1 | 2006 | 258 | 0.020 |
Why?
|
Premedication | 1 | 1985 | 43 | 0.020 |
Why?
|
Polyethylene Glycols | 1 | 2007 | 225 | 0.020 |
Why?
|
Atrophy | 1 | 2006 | 228 | 0.020 |
Why?
|
Cohort Studies | 1 | 2014 | 4795 | 0.020 |
Why?
|
Stomach | 2 | 2003 | 272 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2010 | 8190 | 0.010 |
Why?
|
Capsules | 1 | 2005 | 21 | 0.010 |
Why?
|
Tablets | 1 | 2005 | 28 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2012 | 1684 | 0.010 |
Why?
|
Treatment Failure | 1 | 2006 | 337 | 0.010 |
Why?
|
Anesthetics, Local | 1 | 1985 | 84 | 0.010 |
Why?
|
Cell Membrane | 1 | 2006 | 461 | 0.010 |
Why?
|
Immunoglobulin M | 1 | 2005 | 212 | 0.010 |
Why?
|
Arthritis | 1 | 2005 | 80 | 0.010 |
Why?
|
Polymerase Chain Reaction | 2 | 1999 | 1586 | 0.010 |
Why?
|
Peru | 2 | 1996 | 47 | 0.010 |
Why?
|
Virulence | 1 | 2004 | 262 | 0.010 |
Why?
|
Chemical and Drug Induced Liver Injury | 1 | 1985 | 107 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2015 | 6533 | 0.010 |
Why?
|
Interleukins | 1 | 2004 | 120 | 0.010 |
Why?
|
Sodium Bicarbonate | 1 | 2004 | 52 | 0.010 |
Why?
|
Video Recording | 1 | 2005 | 182 | 0.010 |
Why?
|
Carbon Radioisotopes | 1 | 2003 | 71 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2005 | 691 | 0.010 |
Why?
|
Blotting, Western | 1 | 2005 | 1102 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2003 | 429 | 0.010 |
Why?
|
Incidence | 1 | 2010 | 3138 | 0.010 |
Why?
|
Analysis of Variance | 2 | 1994 | 1014 | 0.010 |
Why?
|
Lipoproteins, VLDL | 1 | 2001 | 58 | 0.010 |
Why?
|
gamma-Glutamyltransferase | 1 | 2000 | 47 | 0.010 |
Why?
|
Aspartate Aminotransferases | 1 | 2000 | 81 | 0.010 |
Why?
|
Alkaline Phosphatase | 1 | 2000 | 97 | 0.010 |
Why?
|
Alanine Transaminase | 1 | 2000 | 156 | 0.010 |
Why?
|
Hyperlipidemias | 1 | 2001 | 176 | 0.010 |
Why?
|
Polyomavirus | 1 | 1999 | 32 | 0.010 |
Why?
|
Drug Resistance, Microbial | 1 | 2000 | 193 | 0.010 |
Why?
|
Drug Resistance | 1 | 2000 | 257 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2007 | 3729 | 0.010 |
Why?
|
DNA, Viral | 1 | 1999 | 480 | 0.010 |
Why?
|
Antibodies | 1 | 1999 | 373 | 0.010 |
Why?
|
Recombination, Genetic | 1 | 1999 | 448 | 0.010 |
Why?
|
China | 2 | 1988 | 243 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2006 | 3424 | 0.010 |
Why?
|
Immunomagnetic Separation | 1 | 1996 | 12 | 0.010 |
Why?
|
RNA, Bacterial | 1 | 1996 | 54 | 0.010 |
Why?
|
Spodoptera | 1 | 1996 | 44 | 0.010 |
Why?
|
Consumer Product Safety | 1 | 1996 | 29 | 0.010 |
Why?
|
Adhesins, Bacterial | 1 | 1996 | 75 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 1 | 1996 | 395 | 0.010 |
Why?
|
Genes, Bacterial | 1 | 1996 | 209 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2004 | 5145 | 0.010 |
Why?
|
RNA, Ribosomal, 16S | 1 | 1996 | 369 | 0.010 |
Why?
|
Blood Urea Nitrogen | 1 | 1994 | 73 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 1999 | 1758 | 0.010 |
Why?
|
Nitrogen | 1 | 1994 | 146 | 0.010 |
Why?
|
Drug Evaluation | 1 | 1993 | 107 | 0.010 |
Why?
|
Deuterium | 1 | 1993 | 109 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1994 | 891 | 0.010 |
Why?
|
Oxidation-Reduction | 1 | 1994 | 440 | 0.010 |
Why?
|
Potassium | 1 | 1994 | 280 | 0.010 |
Why?
|
Veterans | 1 | 2004 | 1755 | 0.010 |
Why?
|
Breast Feeding | 1 | 1993 | 218 | 0.010 |
Why?
|
Amino Acids | 1 | 1994 | 664 | 0.010 |
Why?
|
Housing | 1 | 1991 | 59 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 1996 | 3878 | 0.010 |
Why?
|
Social Class | 1 | 1991 | 190 | 0.010 |
Why?
|
Sensory Thresholds | 1 | 1989 | 35 | 0.000 |
Why?
|
Mucous Membrane | 1 | 1989 | 88 | 0.000 |
Why?
|
Enterotoxins | 1 | 1988 | 82 | 0.000 |
Why?
|
Vaccines, Inactivated | 1 | 1988 | 145 | 0.000 |
Why?
|
Odds Ratio | 1 | 1991 | 1254 | 0.000 |
Why?
|
Bacterial Toxins | 1 | 1988 | 175 | 0.000 |
Why?
|
Pyloric Antrum | 1 | 1987 | 64 | 0.000 |
Why?
|
India | 1 | 1988 | 214 | 0.000 |
Why?
|
Benzalkonium Compounds | 1 | 1985 | 3 | 0.000 |
Why?
|
Cetrimonium Compounds | 1 | 1985 | 4 | 0.000 |
Why?
|
Gastroscopes | 1 | 1985 | 7 | 0.000 |
Why?
|
para-Aminobenzoates | 1 | 1985 | 5 | 0.000 |
Why?
|
Benzocaine | 1 | 1985 | 5 | 0.000 |
Why?
|
Mouthwashes | 1 | 1985 | 10 | 0.000 |
Why?
|
Tetracaine | 1 | 1985 | 9 | 0.000 |
Why?
|
Solutions | 1 | 1985 | 65 | 0.000 |
Why?
|
Taste | 1 | 1985 | 31 | 0.000 |
Why?
|
Lidocaine | 1 | 1985 | 48 | 0.000 |
Why?
|
Fiber Optic Technology | 1 | 1985 | 46 | 0.000 |
Why?
|
Aerosols | 1 | 1985 | 65 | 0.000 |
Why?
|
Intestines | 1 | 1988 | 574 | 0.000 |
Why?
|
Prevalence | 1 | 1991 | 2445 | 0.000 |
Why?
|
Drug Combinations | 1 | 1985 | 267 | 0.000 |
Why?
|
Vaccination | 1 | 1988 | 953 | 0.000 |
Why?
|